NEW YORK (Reuters Health) – For patients with Alzheimer’s disease, prophylactic treatment with divalproex sodium does not delay the emergence of agitation or psychosis, or slow the progression…
Anthony Geraci, MD, Founder and President, neurOasis, provides an overview of the various treatments for migraine, including a class of medication called triptans and a new drug technology…
Anthony Geraci, MD, Founder and President, neurOasis, discusses the prevalence and hallmarks of migraines and what doctors and patients need to know when diagnosing the condition. A key…
NEW YORK (Reuters Health) – Results of two phase II trials investigating the addition of bortezomib to combination treatments of follicular lymphoma suggest that the strategy is feasible…
NEW YORK (Reuters Health) – Cardiac resynchronization therapy not only reduces the risk of a first heart failure event but also recurring events, according to an analysis of…
NEW YORK (Reuters Health) – Among children between 24 and 59 months of age, vaccination with trivalent inactivated influenza vaccine (TIV) is not associated with any serious adverse…
NEW YORK (Reuters Health) – Despite changes in the flora responsible for microbial keratitis, second-generation fluoroquinolone monotherapy remains the empirical treatment of choice, researchers from the UK report…
NEW YORK (Reuters Health) – Radiofrequency ablation (RFA) is a viable alternative in patients with early hepatocellular carcinoma who are not candidates for surgery, Taiwanese researchers report in…
NEW YORK (Reuters Health) – Treatment of isolated diastolic hypertension in patients with cerebrovascular disease protects against major vascular events, according to results from the PROGRESS trial. “For…
NEW YORK (Reuters Health) – One in twenty ischemic strokes occurs within 60 days of withdrawal of antithrombotic agents, according to a report in the June 30th online…
NEW YORK (Reuters Health) – Pneumothorax occurs in 15% of patients having a transthoracic needle biopsy of a pulmonary nodule, according to the findings of a population-based cross-sectional…
NEW YORK (Reuters Health) – For STEMI patients with multivessel coronary disease undergoing primary percutaneous coronary intervention, outcomes are better when revascularization is targeted to just the culprit…
